background
outbreak
coronaviru
diseas
caus
sever
acut
respiratori
syndrom
coronaviru
china
declar
public
health
emerg
intern
concern
cardiac
injuri
common
condit
among
hospit
patient
howev
whether
n
termin
pro
b
type
natriuret
peptid
ntprobnp
predict
outcom
sever
patient
unknown
method
studi
initi
enrol
patient
sever
continu
sampl
screen
inelig
case
patient
analyz
studi
primari
outcom
inhospit
death
defin
case
fatal
rate
research
inform
followingup
data
obtain
medic
record
result
best
cutoff
valu
ntprobnp
predict
inhospit
death
pgml
sensit
specif
patient
high
ntprobnp
valu
pgml
significantli
increas
risk
death
day
followingup
compar
low
valu
pgml
adjust
potenti
risk
factor
ntprobnp
independ
correl
inhospit
death
conclus
ntprobnp
might
independ
risk
factor
inhospit
death
patient
sever
outbreak
coronaviru
diseas
covid
caus
sever
acut
respiratori
syndrom
coronaviru
china
declar
public
health
emerg
intern
concern
januari
despit
lower
case
fatal
rate
kill
peopl
sar
mer
number
keep
grow
epidem
studi
describ
patient
sever
like
develop
advers
clinic
outcom
complic
includ
acut
respiratori
distress
syndrom
acut
cardiac
injuri
acut
kidney
injuri
shock
investig
prognost
marker
sever
patient
provid
insight
earli
therapeut
strategi
cardiac
injuri
common
condit
among
hospit
patient
recent
report
patient
total
case
cardiac
injuri
advers
clinic
outcom
compar
without
cardiac
injuri
guo
et
al
also
report
patient
elev
tnt
level
higher
mortal
retrospect
singlecent
case
seri
patient
studi
report
patient
complic
acut
cardiac
injuri
arrhythmia
respect
fraction
acut
cardiac
injuri
arrhythmia
even
higher
sever
patient
percentag
respect
patient
sever
also
show
higher
creatin
kinasemb
ckmb
hypersensit
troponin
hstni
level
other
recent
studi
demonstr
heart
failur
marker
n
termin
pro
b
type
natriuret
peptid
ntprobnp
increas
significantli
cours
hospit
ultim
die
howev
research
concern
whether
ntprobnp
predict
outcom
sever
patient
studi
initi
enrol
patient
sever
continu
sampl
hubei
gener
hospit
manag
nation
medic
team
studi
retrospect
observ
registri
clinicaltrialsgov
identifi
studi
also
regist
chines
medic
research
registr
inform
system
procedur
follow
instruct
local
ethic
committe
approv
criteria
sever
condit
includ
respiratori
rate
rest
oxyhemoglobin
satur
spo
oxygen
index
arteri
oxygen
tension
inspir
oxygen
fraction
mmhg
data
collect
use
protocol
welltrain
research
doubleblind
method
patient
lack
ntprobnp
result
n
exclud
patient
stroke
n
acut
myocardi
infarct
n
exclud
exclus
criteria
includ
patient
malign
tumor
n
pregnanc
n
also
taken
account
final
patient
studi
research
demograph
data
clinic
featur
medic
histori
avail
collect
accord
patient
record
system
data
collect
laboratori
result
defin
use
firsttim
examin
admiss
within
h
admiss
laboratori
data
test
laboratori
standard
observ
risk
inhospit
death
patient
follow
admiss
discharg
day
primari
outcom
inhospit
death
defin
case
fatal
rate
followup
data
collect
review
medic
record
train
research
use
doubleblind
method
data
present
mean
standard
deviat
frequenc
median
interquartil
rang
intergroup
comparison
ntprobnp
high
group
low
group
made
independentsampl
ttest
normal
distribut
continu
variabl
mannwhitney
u
test
nonnorm
distribut
continu
variabl
chisquar
test
categor
variabl
best
ntprobnp
cutoff
highest
product
sensit
specif
inhospit
death
predict
cumul
surviv
curv
inhospit
death
estim
use
kaplanmei
productlimit
estim
method
logrank
test
spearman
correl
analysi
use
investig
coeffici
ntprobnp
select
covari
cox
proport
hazard
model
use
screen
potenti
risk
factor
analyz
independ
effect
ntprobnp
inhospit
death
statist
analys
perform
spss
spss
chicago
il
usa
twosid
p
consid
statist
signific
baselin
characterist
particip
divid
two
group
low
high
ntprobnp
level
pgml
ntprobnp
pg
ml
tabl
accord
cutoff
valu
determin
roc
curv
fig
patient
ntprobnp
high
group
significantli
older
comorbid
hypertens
hp
coronari
heart
diseas
chd
higher
level
diastol
blood
pressur
dbp
myohemoglobin
myo
ckmb
hstni
blood
urea
creatinin
white
blood
cell
wbc
creactiv
protein
crp
procalcitonin
pct
lower
level
lymphocyt
lym
particip
ntprobnp
low
group
characterist
like
sex
temperatur
puls
rate
respiratori
rate
systol
blood
pressur
histori
chronic
obstruct
pulmonari
diseas
copd
diabet
show
signific
two
group
differ
level
ntprobnp
tabl
receiv
oper
characterist
roc
curv
shown
fig
analyz
prognost
valu
best
cutoff
ntprobnp
predict
inhospit
death
area
curv
auc
inhospit
death
ci
p
best
cutoff
ntprobnp
predict
inhospit
death
pgml
sensit
specif
fig
cumul
surviv
rate
curv
two
group
categor
ntprobnp
cutoff
valu
shown
present
studi
plasma
ntprobnp
posit
correl
age
urea
cardiac
injuri
marker
myo
ckmb
hstni
systemat
inflamm
maker
wbc
crp
hscrp
pct
supplement
tabl
cox
proport
hazard
regress
analysi
use
evalu
potenti
associ
ntprobnp
inhospit
death
result
univari
analys
show
hazard
ratio
hr
ntprobnp
associ
inhospit
death
ci
p
increas
pgml
meanwhil
age
male
histori
hypertens
hp
myoglobin
myo
creatin
kinasemb
ckmb
highsensit
troponini
hstni
urea
creatinin
white
blood
cell
wbc
lymphocyt
lym
creactiv
protein
crp
procalcitonin
pct
correl
risk
inhospit
death
tabl
multivari
cox
proport
hazard
regress
analys
use
evalu
independ
prognost
effect
ntprobnp
level
adjust
sex
age
mode
hr
ntprobnp
inhospit
death
ci
p
increas
pgml
adjust
hp
chd
histori
mode
hr
ci
p
adjust
myo
ckmb
hstni
mode
hr
ci
p
adjust
urea
creatinin
fig
present
studi
first
time
show
relationship
plasma
ntprobnp
level
risk
inhospit
death
sever
patient
sever
patient
high
ntprobnp
level
tend
older
increas
cardiac
injuri
marker
higher
level
systemat
inflamm
marker
patient
high
ntprobnp
pgml
level
lower
cumul
surviv
rate
adjust
potenti
cofound
separ
mode
ntprobnp
present
independ
risk
factor
inhospit
death
patient
sever
previou
studi
found
ntprobnp
power
independ
predictor
mortal
communityacquir
pneumonia
cap
studi
best
cutoff
valu
ntprobnp
predict
mortal
pgml
pg
ml
respect
elev
ntprobnp
case
believ
owe
cardiac
complic
result
complex
interact
among
preexist
condit
rel
ischemia
upregul
sympathet
system
system
inflamm
direct
pathogenmedi
damag
cardiovascular
system
howev
cutoff
valu
ntprobnp
predict
advers
outcom
sever
patient
far
lower
threshold
diagnos
heart
failur
pgml
year
pgml
year
pgml
year
present
studi
suggest
prognost
effect
plasma
ntprobnp
sever
patient
could
fulli
ascrib
heart
failur
induc
viru
hypoxia
understand
physiolog
patholog
signific
plasma
ntprobnp
elev
sever
patient
might
help
clinician
make
correspond
decis
reduc
risk
advers
outcom
ntprobnp
secret
respons
increas
myocardi
wall
stress
also
control
acut
renal
injuri
proinflammatori
molecul
lipopolysaccharid
interleukin
creactiv
protein
cardiotrophin
independ
ventricular
function
consist
studi
find
ntprobnp
level
posit
correl
maker
cardiac
injuri
renal
injuri
systemat
inflamm
maker
also
constitut
risk
inhospit
death
accord
univari
cox
proportionalhazard
regress
analysi
howev
ntprobnp
independ
risk
factor
account
factor
multivari
cox
prognost
effect
ntprobnp
might
specif
index
reflect
overal
state
infect
mechan
cardiac
injuri
still
unclear
result
autopsi
xu
colleagu
interstiti
mononuclear
inflammatori
infiltr
observ
heart
biopsi
indic
inflamm
induc
cardiac
injuri
factor
includ
infect
invas
cardiomyocyt
via
bind
site
angiotensinconvert
enzymerel
carboxypeptidas
pulmonari
infect
induc
inadequ
oxygen
suppli
myocardium
influenc
cytokin
storm
syndrom
might
also
contribut
cardiac
injuri
contribut
elev
ntprobnp
risk
poor
prognosi
patient
viru
may
also
elev
ntprobnp
level
patient
bind
result
uncontrol
releas
angiotensin
angii
restrict
synthesi
latter
exert
antiinflamm
effect
protect
tissu
angii
play
opposit
role
facilit
secret
ntprobnp
indic
ntprobnp
level
might
associ
sever
infect
thu
lead
advers
outcom
need
verif
investig
prognost
effect
ntprobnp
level
sever
patient
admiss
might
help
earli
identifi
patient
poor
prognos
howev
studi
limit
sampl
size
singl
test
ntprobnp
admiss
larger
studi
continu
monitor
ntprobnp
necessari
confirm
prognost
effect
ntprobnp
patient
sever
conclus
ntprobnp
might
independ
risk
factor
inhospit
death
patient
sever
supplementari
inform
accompani
paper
http
addit
file
